{"issuance_frequency":"","notes_translated":{"fr":"Promotion de la santé et prévention des maladies chroniques au Canada : Recherche, politiques et pratiques (la revue PSPMC) est la revue scientifique mensuelle en ligne de la Direction générale de la promotion de la santé et de la prévention des maladies chroniques de l'Agence de la santé publique du Canada.Elle contient des articles sur la prévention des maladies, la promotion de la santé et l'équité en santé dans les domaines des maladies chroniques, des blessures et de la santé à toutes les étapes de la vie. Le contenu inclut des travaux de recherche dans divers domaines, notamment la santé publique et communautaire, l'épidémiologie, la biostatistique, les sciences comportementales et sociales, les services de santé et l'économie.\r\n","en":"Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice(the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics.\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","metadata_created":"2019-01-08T22:01:16.828138","subject":["health_and_safety"],"date_modified":"2018-06-13 00:00:00","pspc_identification_number":"","metadata_modified":"2019-01-08T22:01:16.828147","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-01-08","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Ensemble de données probantes","action soutenue","santé publique","crise des opioïdes","Canada","numéro spécial","Synthèse des données probantes","perspective nationale","Tendances canadiennes","mortalité liée aux opioïdes","invalidité","trouble de consommation d'opioïdes","Étude sur la charge mondiale","morbidité","1990-2014","Hospitalisations","visites à l'urgence","empoisonnement aux opioïdes","décès par surdose","drogue","espérance de vie à la naissance","Colombie-Britannique","programme naloxone à emporter à domicile","Manitoba","retrait des opioïdes à forte concentration","schémas de prescription","Ontario","médias sociaux"],"en":["Building evidence base","sustained public health","opioid epidemic","Canada","special issue","Evidence synthesis","opioid crisis","national perspective","Canadian trends","opioid-related mortality","disability","opioid use disorder","1990 to 2014","Global Burden of Disease Study","Hospitalizations","emergency department visits","opioid poisoning","drug overdose","deaths","life expectancy at birth","British Columbia","Manitoba","Take-Home Naloxone","delisting high-strength opioids","patterns of prescribing","Ontario","social media"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Volume 38, no 6, juin 2018, Promotion de la santé et prévention des maladies chroniques au Canada","en":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"623e9fdd-2bd5-461a-ba0b-9dd956be2127","related_relationship":"","name_translated":{"fr":"Volume 38, no 6, juin 2018, Promotion de la santé et prévention des maladies chroniques au Canada","en":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada","language":["en"],"created":"2019-01-08T22:01:17.975511","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018.html","last_modified":null,"position":0,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d17e6b39-d0d9-4da1-bc57-3a9c3a7e8f42","related_relationship":"","name_translated":{"fr":"Volume 38, no 6, juin 2018, Promotion de la santé et prévention des maladies chroniques au Canada","en":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada","language":["fr"],"created":"2019-01-08T22:01:17.975519","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018.html","last_modified":null,"position":1,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6f087eba-0100-4d18-b87f-5837f78191b5","related_relationship":"","name_translated":{"fr":"Volume 38, no 6, juin 2018, Promotion de la santé et prévention des maladies chroniques au Canada","en":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada","language":["en"],"created":"2019-01-08T22:01:17.975522","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/hpcdp-38-6-eng.pdf","last_modified":null,"position":2,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8bad2f6a-10d2-42ba-9c09-1cfc859660d3","related_relationship":"","name_translated":{"fr":"Volume 38, no 6, juin 2018, Promotion de la santé et prévention des maladies chroniques au Canada","en":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada","language":["fr"],"created":"2019-01-08T22:01:17.975524","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/hpcdp-38-6-fra.pdf","last_modified":null,"position":3,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9ad052ad-ca23-41a0-bb8e-1ac8afe14a3a","related_relationship":"","name_translated":{"fr":"Commentaire – Constituer un ensemble de données probantes au service d'une action soutenue en santé publique en réponse à la crise des opioïdes au Canada","en":"Commentary – Building the evidence base for sustained public health response to the opioid epidemic in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Commentary – Building the evidence base for sustained public health response to the opioid epidemic in Canada","language":["en"],"created":"2019-01-08T22:01:17.975526","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/building-evidence-base-sustained-public-health-response-opioid-epidemic-canada.html","last_modified":null,"position":4,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"18a09f13-cb12-4f38-bd0b-ff0964d422e9","related_relationship":"","name_translated":{"fr":"Commentaire – Constituer un ensemble de données probantes au service d'une action soutenue en santé publique en réponse à la crise des opioïdes au Canada","en":"Commentary – Building the evidence base for sustained public health response to the opioid epidemic in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Commentary – Building the evidence base for sustained public health response to the opioid epidemic in Canada","language":["fr"],"created":"2019-01-08T22:01:17.975529","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/constituer-ensemble-donnees-probantes-service-action-soutenue-sante-publique-reponse-crise-opioides-canada.html","last_modified":null,"position":5,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c78dbf42-6fbe-4f71-8202-5874020607f9","related_relationship":"","name_translated":{"fr":"Remarque générale au sujet du numéro spécial","en":"General note about the special issue"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"General note about the special issue","language":["en"],"created":"2019-01-08T22:01:17.975531","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/note-special-issue-opioids-crisis-canada.html","last_modified":null,"position":6,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cb7e18ce-5183-4776-aa87-50309f316d48","related_relationship":"","name_translated":{"fr":"Remarque générale au sujet du numéro spécial","en":"General note about the special issue"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"General note about the special issue","language":["fr"],"created":"2019-01-08T22:01:17.975533","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/remarque-numero-special-crise-opioides-canada.html","last_modified":null,"position":7,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4fa23be3-f99c-4128-b90e-5cabebfb4d0d","related_relationship":"","name_translated":{"fr":"Synthèse des données probantes – La crise des opioïdes au Canada : une perspective nationale","en":"Evidence synthesis – The opioid crisis in Canada: a national perspective"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evidence synthesis – The opioid crisis in Canada: a national perspective","language":["en"],"created":"2019-01-08T22:01:17.975535","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/evidence-synthesis-opioid-crisis-canada-national-perspective.html","last_modified":null,"position":8,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6e312db2-37f8-4f9f-8f65-4c46d9d857e1","related_relationship":"","name_translated":{"fr":"Synthèse des données probantes – La crise des opioïdes au Canada : une perspective nationale","en":"Evidence synthesis – The opioid crisis in Canada: a national perspective"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evidence synthesis – The opioid crisis in Canada: a national perspective","language":["fr"],"created":"2019-01-08T22:01:17.975538","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/synthese-donnees-probantes-crise-opioides-canada-perspective-nationale.html","last_modified":null,"position":9,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8d9828e8-2597-4667-be6b-f6bc47d8afda","related_relationship":"","name_translated":{"fr":"Tendances canadiennes en matière de mortalité liée aux opioïdes et d'invalidité découlant d'un trouble de consommation d'opioïdes, à la lumière de l'Étude sur la charge mondiale de morbidité (1990-2014)","en":"Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study","language":["en"],"created":"2019-01-08T22:01:17.975540","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/original-quantitative-research-canadian-trends-opioid-related-mortality-disability-1990-2014-lens-global-burden-disease-study.html","last_modified":null,"position":10,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"20a05a36-7c0c-4cdf-b48c-44c9a20d4efc","related_relationship":"","name_translated":{"fr":"Tendances canadiennes en matière de mortalité liée aux opioïdes et d'invalidité découlant d'un trouble de consommation d'opioïdes, à la lumière de l'Étude sur la charge mondiale de morbidité (1990-2014)","en":"Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study","language":["fr"],"created":"2019-01-08T22:01:17.975542","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/recherche-quantitative-originale-tendances-canadiennes-mortalite-liee-opioides-invalidite-1990-2014-a-lumiere-etude-charge-mondiale-morbidite.html","last_modified":null,"position":11,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d1450ffe-3d47-436d-9add-06d5660fb250","related_relationship":"","name_translated":{"fr":"Aperçu – Hospitalisations et visites à l'urgence en raison d'un empoisonnement aux opioïdes au Canada","en":"At-a-glance – Hospitalizations and emergency department visits due to opioid poisoning in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – Hospitalizations and emergency department visits due to opioid poisoning in Canada","language":["en"],"created":"2019-01-08T22:01:17.975544","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/at-a-glance-hospitalizations-emergency-visits-opioid-poisoning-canada.html","last_modified":null,"position":12,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8c8eab1e-8f12-414a-ab37-d88c041e8b56","related_relationship":"","name_translated":{"fr":"Aperçu – Hospitalisations et visites à l'urgence en raison d'un empoisonnement aux opioïdes au Canada","en":"At-a-glance – Hospitalizations and emergency department visits due to opioid poisoning in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – Hospitalizations and emergency department visits due to opioid poisoning in Canada","language":["fr"],"created":"2019-01-08T22:01:17.975546","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/apercu-hospitalisations-visites-urgence-empoisonnement-opioides-canada.html","last_modified":null,"position":13,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3015e3fd-8971-49a5-bae2-d1db0cffe9a2","related_relationship":"","name_translated":{"fr":"Aperçu – Impact des décès par surdose de drogue sur l'espérance de vie à la naissance en Colombie-Britannique","en":"At-a-glance – Impact of drug overdose-related deaths on life expectancy at birth in British Columbia"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – Impact of drug overdose-related deaths on life expectancy at birth in British Columbia","language":["en"],"created":"2019-01-08T22:01:17.975549","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/at-a-glance-impact-overdose-related-deaths-life-expectancy-at-birth-british-columbia.html","last_modified":null,"position":14,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"36035a98-2464-45c2-a599-3e07baf5bf0a","related_relationship":"","name_translated":{"fr":"Aperçu – Impact des décès par surdose de drogue sur l'espérance de vie à la naissance en Colombie-Britannique","en":"At-a-glance – Impact of drug overdose-related deaths on life expectancy at birth in British Columbia"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – Impact of drug overdose-related deaths on life expectancy at birth in British Columbia","language":["fr"],"created":"2019-01-08T22:01:17.975551","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/apercu-impact-deces-surdose-esperance-vie-naissance-colombie-britannique.html","last_modified":null,"position":15,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"206a29f6-cf51-4ae7-a603-6bd34928b505","related_relationship":"","name_translated":{"fr":"Aperçu – Leçons tirées du lancement du programme de naloxone à emporter à domicile du Manitoba","en":"At-a-glance – Lessons learned from launching the Manitoba Take-Home Naloxone Program"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – Lessons learned from launching the Manitoba Take-Home Naloxone Program","language":["en"],"created":"2019-01-08T22:01:17.975553","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/at-a-glance-lessons-learned-manitoba-take-home-naloxone-program.html","last_modified":null,"position":16,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0f47bf32-aaa7-4c8c-91be-6b0459a407d9","related_relationship":"","name_translated":{"fr":"Aperçu – Leçons tirées du lancement du programme de naloxone à emporter à domicile du Manitoba","en":"At-a-glance – Lessons learned from launching the Manitoba Take-Home Naloxone Program"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – Lessons learned from launching the Manitoba Take-Home Naloxone Program","language":["fr"],"created":"2019-01-08T22:01:17.975555","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/apercu-lecons-tirees-programme-naloxone-emporter-domicile-manitoba.html","last_modified":null,"position":17,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fcb0c61b-e30e-47d9-90c0-7b976d8427b9","related_relationship":"","name_translated":{"fr":"Évaluation des premiers effets du retrait des opioïdes à forte concentration sur les schémas de prescription en Ontario","en":"Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario","language":["en"],"created":"2019-01-08T22:01:17.975557","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/original-quantitative-research-evaluating-early-impacts-delisting-high-strength-opioids-patterns-prescribing-ontario.html","last_modified":null,"position":18,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"bb9643c4-6a4f-4708-bd52-a49982017450","related_relationship":"","name_translated":{"fr":"Évaluation des premiers effets du retrait des opioïdes à forte concentration sur les schémas de prescription en Ontario","en":"Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario","language":["fr"],"created":"2019-01-08T22:01:17.975560","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/recherche-quantitative-originale-evaluation-premierseeffets-retrait-opioides-forte-concentration-schemas-prescription-ontario.html","last_modified":null,"position":19,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1a33ce60-d062-4422-963c-4ac86d43af23","related_relationship":"","name_translated":{"fr":"Aperçu – Que révèlent les médias sociaux au sujet de la crise des opioïdes au Canada?","en":"At-a-glance – What can social media tell us about the opioid crisis in Canada?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – What can social media tell us about the opioid crisis in Canada?","language":["en"],"created":"2019-01-08T22:01:17.975562","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/at-a-glance-what-social-media-tells-about-opioid-crisis-canada.html","last_modified":null,"position":20,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7dc3b7e7-4481-4eff-bb1f-ce6615d136b8","related_relationship":"","name_translated":{"fr":"Aperçu – Que révèlent les médias sociaux au sujet de la crise des opioïdes au Canada?","en":"At-a-glance – What can social media tell us about the opioid crisis in Canada?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"At-a-glance – What can social media tell us about the opioid crisis in Canada?","language":["fr"],"created":"2019-01-08T22:01:17.975564","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/apercu-que-revelent-medias-sociaux-crise-opioides-canada.html","last_modified":null,"position":21,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8de6e2c8-06e9-410f-98c4-168d114cfd58","related_relationship":"","name_translated":{"fr":"Autres publications de l'ASPC","en":"Other PHAC publications"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Other PHAC publications","language":["en"],"created":"2019-01-08T22:01:17.975566","url":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-38-no-6-2018/other-phac-publications.html","last_modified":null,"position":22,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4ea752cc-f531-4182-bc4a-6473a6e3ce55","related_relationship":"","name_translated":{"fr":"Autres publications de l'ASPC","en":"Other PHAC publications"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Other PHAC publications","language":["fr"],"created":"2019-01-08T22:01:17.975569","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/promotion-sante-prevention-maladies-chroniques-canada-recherche-politiques-pratiques/vol-38-no-6-2018/autres-publications-aspc.html","last_modified":null,"position":23,"revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d","resource_type":"website"}],"place_of_publication":[],"num_resources":24,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2018-06-13 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"9a1ffa1c-2e2a-4f7c-938b-dc9c69c49003","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice(the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics.\r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Vol 38, No 6, June 2018, Health Promotion and Chronic Disease Prevention in Canada","revision_id":"3b24fb79-58e9-4c35-94e3-a8800300a55d"}